CIARA WHITE: Open Payments
NPI 1407517923 · PEORIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$624 in 32 payments from 11 companies in 2025. Trend: 2023 $277 · 2024 $820 · 2025 $624
Food & beverage: $624
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $153 |
| Gilead Sciences, Inc. | 7 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Neurocrine BioSciences, Inc. | 3 | $63 |
| PFIZER INC. | 3 | $51 |
| Abbott Laboratories | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| SANOFI PASTEUR INC. | 1 | $24 |
| Alkermes, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: REXULTI, CAPLYTA, INGREZZA, PREVNAR 20, ABILIFY ASIMTUFII, FREESTYLE LIBRE 3, Kerendia, BEYFORTUS.
Industry payments across IL — which companies pay providers there.
